• Publications
  • Influence
Changing incidence of glomerular diseases in adults.
Studies performed at large metropolitan medical centers have reported an increasing incidence of idiopathic focal segmental glomerulosclerosis (FSGS) in adults. To determine whether a similar trendExpand
  • 222
  • 14
Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.
Patients with advanced chronic kidney disease (CKD) have a high burden of physical and psychosocial symptoms, poor outcomes, and high costs of care. Current paradigms of care for this highlyExpand
  • 236
  • 10
  • PDF
Advance care planning: a qualitative study of dialysis patients and families.
BACKGROUND AND OBJECTIVES More than 90,000 patients with ESRD die annually in the United States, yet advance care planning (ACP) is underutilized. Understanding patients' and families' diverse needsExpand
  • 57
  • 7
  • PDF
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
BACKGROUND Calcitriol lowers parathyroid hormone (PTH) levels in patients with chronic kidney disease (CKD) stages 3 and 4, but its use is limited by a low therapeutic index and concerns regardingExpand
  • 156
  • 6
  • PDF
Renal palliative care.
Patients with chronic kidney disease have a shortened life expectancy and carry a high symptom burden. Clinicians need sophisticated expertise in pain and symptom management and skills inExpand
  • 111
  • 6
Predicting six-month mortality for patients who are on maintenance hemodialysis.
BACKGROUND AND OBJECTIVES Prognostic information is rarely conveyed by nephrologists because of clinical uncertainty about accuracy. The objective of this study was to develop an integratedExpand
  • 304
  • 5
  • PDF
IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients
Abstract Objective: To examine the hypothesis that 12 weeks of resistance training would alter circulating concentrations of IGF-I system components in end-stage renal disease (ESRD) patients.Expand
  • 49
  • 5
Update on psychotropic medication use in renal disease.
Renal failure is a common medical condition, and many patients have comorbid psychiatric disorders. In this review, which is intended as a resource for consultation psychiatrists, the authors discussExpand
  • 52
  • 5
Dialysis discontinuation. A 'good' death?
BACKGROUND Approximately 10% of the deaths of patients receiving long-term dialysis for end-stage renal disease are preceded by discontinuation of dialysis. We prospectively studied the decision toExpand
  • 102
  • 3
A palliative approach to dialysis care: a patient-centered transition to the end of life.
As the importance of providing patient-centered palliative care for patients with advanced illnesses gains attention, standard dialysis delivery may be inconsistent with the goals of care for manyExpand
  • 88
  • 3
  • PDF